A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release

A press release from a Canadian research group raised hopes that treating people recently diagnosed with Covid-19 with colchicine, a drug commonly used to treat gout, could reduce the risk they will need to be hospitalized.